Background: Schizophrenia is among the major causes of disability worldwide and the
mortality from cardiovascular disease (CVD) is significantly elevated. There is a growing …

Cardiovascular disease (CVD), which includes coronary heart, cerebrovascular, and
peripheral vascular disease, is the leading cause of death in the United States and most …

The presence of comorbid physical illnesses especially, cardiovascular diseases (CVD) in
schizophrenia is a growing area of concern in recent years. In order to reduce disease …

Patients with schizophrenia are at higher risk for medical illnesses than people in the
general population. Electrocardiographic and metabolic abnormalities that occur in patients …

OBJECTIVE: To evaluate the prevalence of cardiovascular risk factors (CV-RF) and disease
(CV-D) in people with schizophrenia. METHOD: We conducted a period-prevalence study …

Cardiovascular morbidity and mortality are important problems among patients with
schizophrenia. A wide spectrum of reasons, ranging from genes to the environment, are held …

Background: Cardiovascular disease (CVD) mortality in schizophrenia is more frequent than
in the general population. Whether second-generation antipsychotics (SGAs) increase risk …

BackgroundPatients with schizophrenia have excess cardiovascular morbidity and mortality.
Previous studies suggest that this may be partly due to inadequate somatic treatment and …

OBJECTIVE: The aim of the study is to review the absolute and relative impacts of the major
causes for premature mortality among patients with schizophrenia. DATA SOURCES: We …

AimsPeople who have schizophrenia die earlier from somatic diseases than do people in
the general population, but information about cardiovascular deaths in people who have …